New test could predict immunotherapy success in blood cancers
NCT ID NCT07018310
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop a simple blood test that checks how well a person's immune cells can fight blood cancer. Researchers will collect blood samples from 166 adults with blood cancers to measure immune cell activity and look at genetic factors. The goal is to create a test that doctors can use in the future to decide if immunotherapy will work for a patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assisitance Publique Hôpitaux de Marseille
Marseille, 13005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a walk a day keep brain fog away after a stem cell transplant?
- Ancient herb, modern hope: ashwagandha compound tested to prevent deadly transplant complication
- Ancient herb takes on transplant complication: Withaferin-A tested for Steroid-Resistant GVHD
- New program helps caregivers of stem cell patients cope better
- New antibiotic could shield blood cancer patients from deadly infections
- Can a common asthma drug stop post-transplant fevers?